Iranian Journal of Allergy, Asthma and Immunology 2017. 16(6):480-487.

Characteristics, Etiology and Treatment of Pediatric and Adult Anaphylaxis in Iran
Mohammad Nabavi, Mehrnoosh Lavavpour, Saba Arshi, Mohammad Hasan Bemanian, Hossein Esmaeilzadeh, Rasool Molatefi, Mahsa Rekabi, Javad Ahmadian, Narges Eslami, Sima Shokri, Kian Darabi, Gholam Reza Sedighi, Morteza Fallahpour


Despite the increasing prevalence of anaphylaxis, there is little information about the characteristics and practice of healthcare providers in treating anaphylaxis, so this study was conducted to record the characteristics and therapeutic approaches of anaphylaxis from May 2012 until April 2015, the data of all patients diagnosed with anaphylaxis in the Allergy department of three referral university hospitals in Tehran, Iran were recorded. Thereafter, the demographics, clinical features, triggers and therapeutic approach were evaluated. This study investigated 136 individuals, 64 males (47%) between 6 months and 68 years old, as well as 72 others (52.94%) under 18 years of age (pediatric). The following were the most common organs involved: Skin 86.02% (pediatric 91.66% vs adult 79.68%), respiratory tract 51.47% (pediatric 43.05% vs adult 60.93%), cardiovascular 50.73% (pediatric 54.16% vs adult 46.87%), gastrointestinal 20.58% (pediatric 27.7% vs adult 12.5% ) and neurologic system 5.88% (only in adults). The following were the most identified causing foods 69 (50.37%)[42 pediatric (children) and 27 adults], drugs 34( 25%)[14 pediatric and 20 adults], idiopathic 16( 11.77%)[3 pediatric and 13 adults], insect sting 7( 5.15%)[3 pediatric and 4 adults] , exercise 6( 4.42%) [1 pediatric and 5 adults]. Milk, egg and wheat were the most common causative foods in pediatric cases but sesame, as well as egg and milk were the most common causes in adults. Epinephrine injection, auto injector epinephrine prescription as a discharging plan and referral to an allergist were: 10.78, 1.96 and 7.8 %, respectively. In this case series we found that, cutaneous, respiratory, cardiovascular and gastrointestinal complains were the most common manifestations and food, drug and idiopathic were the most common causes.In this study, the diagnosis of anaphylaxis, epinephrine subscription and referral to an allergist were significantly lower in comparison to other studies.


Adult anaphylaxis; Anaphylaxis registry; Anaphylaxis etiology; Anaphylaxis treatment; Children anaphylaxis

Full Text:



1.         Lieberman PL. 2014. Recognition and first-line treatment of anaphylaxis. The American

 journal of medicine 127: S6-S11


2.         Muraro A, Roberts G, Worm M, et al. 2014. Anaphylaxis: guidelines from the european

academy of allergy and clinical immunology. Allergy 69: 1026-45


3. Teymourpour P,  Pourpak Z, Fazlollahi M R  et al. Cow’s Milk Anaphylaxis in Children

First Report of Iranian Food Allergy Registry. Iran J Allergy Asthma Immunol

March 2012; 11(1): 29-36.


4. Teymourpour P, Shokouhi R, Fazlollahi M R et al. Factors Affecting the Severity of Cow’s

Milk Anaphylaxis. Iran J Allergy Asthma Immunol .June 2013; 12(2):190-191


5.         Campbell RL, Li J, Nicklas RA, Sadosty AT. 2014. Emergency department diagnosis and

treatment of anaphylaxis: a practice parameter. Ann Allergy Asthma Immunol 113: 599-608


6.         Nowak R, Farrar JR, Brenner BE et al. 2013. Customizing anaphylaxis guidelines for

emergency medicine. The Journal of emergency medicine 45: 299-306


7.         Alonso T, Moro Moro M, García M. 2015. Epidemiology of anaphylaxis. Clinical &

 Experimental Allergy 45: 1027-39


8.         Ben‐Shoshan M, Clarke A. 2011. Anaphylaxis: past, present and future. Allergy 66: 1-14


9.         Koplin JJ, Martin PE, Allen KJ. 2011. An update on epidemiology of anaphylaxis in

children and adults. Current opinion in allergy and clinical immunology 11: 492-6


10.       Fineman SM, Bowman SH, Campbell RL et al. 2015. Addressing barriers to emergency

anaphylaxis care: from emergency medical services to emergency department to outpatient

follow-up. Annals of Allergy, Asthma & Immunology 115: 301-5


11.       Greenberger PA, Rotskoff BD, Lifschultz B. 2007. Fatal anaphylaxis: postmortem

findings and associated comorbid diseases. Annals of allergy, asthma & immunology 98: 252-7


12.       Sclar DA, Lieberman PL. 2014. Anaphylaxis: underdiagnosed, underreported, and

undertreated. The American journal of medicine 127: S1-S5


13.       Lieberman P, Nicklas RA, Randolph C et al. 2015. Anaphylaxisda practice parameter

update 2015. Ann Allergy Asthma Immunol 115: 1e384


14.       Adkinson Jr NF, Bochner BS, Burks AW et al. 2013. Middleton's allergy: principles and

practice: Elsevier Health Sciences


15.       Yi-Chen H, Yi-Chin H, Jing-Long H, Kuo-Wei Y. 2011. Clinical features of adult and

pediatric anaphylaxis in Taiwan. Asian Pacific Journal of Allergy and Immunology 29: 307


16.       Blackhall M, Edwards D. 2015. Incidence and patient demographics of pre-hospital

anaphylaxis in Tasmania. Australasian Journal of Paramedicine 12


17. Barzegar S, Akramian R, Pourpak Z et al. Common Causes of Anaphylaxis in Children

The First Report of Anaphylaxis Registry in Iran, WAO Journal 2010; 3:9–13


18.Worm M, Edenharter G, Rueff F et al. 2012. Symptom profile and risk factors of

anaphylaxis in Central Europe. Allergy 67: 691-8


19.       Yang M-S, Lee S-H, Kim T-W et al. 2008. Epidemiologic and clinical features of

anaphylaxis in Korea. Annals of Allergy, Asthma & Immunology 100: 31-6


20.       Wood RA, Camargo CA, Lieberman P et al.2014. Anaphylaxis in America: the

prevalence and characteristics of anaphylaxis in the United States. Journal of Allergy and

Clinical Immunology 133: 461-7


21.       Jiang N, Yin J, Wen L, Li H. 2016. Characteristics of Anaphylaxis in 907 Chinese

Patients Referred to a Tertiary Allergy Center: A Retrospective Study of 1,952 Episodes.

Allergy, asthma & immunology research 8: 353-61


22.       Kimchi N, Clarke A, Moisan J et al. 2015. Anaphylaxis cases presenting to primary care

paramedics in Quebec. Immunity, inflammation and disease 3: 406-10


23.       Sicherer SH, Muñoz-Furlong A, Godbold JH, Sampson HA. 2010. US prevalence of self-

reported peanut, tree nut, and sesame allergy: 11-year follow-up. Journal of Allergy and Clinical

 Immunology 125: 1322-6


24.       Tejedor-Alonso M, Moro-Moro M, Múgica-García M. 2014. Epidemiology of

Anaphylaxis: Contributions From the Last 10 Years. Journal of investigational allergology &

clinical immunology 25: 163-75; quiz follow 74-5


25.       O'Keefe A, Clarke A, Pierre YS et al. 2016. The Risk of Recurrent Anaphylaxis. The

Journal of Pediatrics


26.       Stukus DR, Mikhail I. 2016. Pearls and Pitfalls in Diagnosing IgE-Mediated Food

Allergy. Current allergy and asthma reports 16: 1-10


27. Akin C. 2010. Anaphylaxis and mast cell disease: what is the risk? Current allergy and

asthma reports 10: 34-8


28.       Gülen T, Hägglund H, Dahlén S-E, Sander B, Dahlén B, Nilsson G. 2014. Flushing,

fatigue, and recurrent anaphylaxis: a delayed diagnosis of mastocytosis. The Lancet 383: 1608


29.       Valent P. 2014. Risk factors and management of severe life‐threatening anaphylaxis in

patients with clonal mast cell disorders. Clinical & Experimental Allergy 44: 914-20


30.       Tejedor-Alonso M, Mugica-García M, Esteban-Hernández J et al. 2013. A study of

recurrence of anaphylaxis in a spanish anaphylaxis series. J Investig Allergol Clin Immunol 23:



31.       Alonso M, García M, Hernández JE et al. 2013. Recurrence of anaphylaxis in a Spanish

series. J Investig Allergol Clin Immunol 23: 383-91


32.       Mullins R. 2003. Anaphylaxis: risk factors for recurrence. Clinical & Experimental

Allergy 33: 1033-40


33.       Brown AF, McKinnon D, Chu K. 2001. Emergency department anaphylaxis: a review of

142 patients in a single year. Journal of Allergy and Clinical Immunology 108: 861-6


34.       Brown S, Blackman K, Stenlake V, Heddle R. 2004. Insect sting anaphylaxis;

prospective evaluation of treatment with intravenous adrenaline and volume resuscitation.

Emergency medicine journal 21: 149-54


35. Hussain AM, Yousuf B, Khan MA, Khan FH, Khan FA. Vasopressin for the management of

catecholamine-resistant anaphylactic shock. Singapore Med J. 2008 Sep;49(9)


36.  Delara Babaie, Mohammad Nabavi, Saba Arsh et al. Cow’s Milk Desensitization in

Anaphylactic Patients: A New Personalized-dose Method. Iran J Allergy Asthma Immunol 16

(16(1)), 45-52


37. M Nabavi, M Rekabi, S Arshi et al. Evaluation of total and specific IgE in serum of wheat

allergy patients before and after of desensitization. Razi Journal of Medical Sciences 23 (144),



38.       Simons FER, Organization WA. 2010. World Allergy Organization survey on global

availability of essentials for the assessment and management of anaphylaxis by allergy-

immunology specialists in health care settings. Annals of Allergy, Asthma & Immunology 104:



39.       Mostmans Y, Grosber M, Blykers M, Mols P, Naeije N, Gutermuth J. 2016. Adrenaline

in anaphylaxis treatment and self‐administration: experience from an inner city emergency

department. Allergy


40.       Sidhu N, Jones S, Perry T et al. 2016. Evaluation of Anaphylaxis Management in a

Pediatric Emergency Department. Pediatric Emergency Care 32: 508-13


41.       Alangari AA. 2014. Characteristics of patients presenting to the emergency department

with anaphylaxis in Riyadh, Saudi Arabia. Journal of Taibah University Medical Sciences 9:



42.       Hitti EA, Zaitoun F, Harmouche E, Saliba M, Mufarrij A. 2015. Acute allergic reactions

in the emergency department: characteristics and management practices. European Journal of

Emergency Medicine 22: 253-9


  • There are currently no refbacks.

Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.